Closing Bell: Stocks Soar, Alzheimer’s Drug Study & “The Next Big Thing” 9/28/22

A big rally on Wall Street after the Bank of England announced it will buy bonds to stabilize its financial markets. Fmr. Fed Vice Chair Richard Clarida reacts to the Bank of England’s move and discusses whether the Federal Reserve is taking the right steps to fight inflation and manage a soft economic landing. Charles Schwab Chief Investment Strategist Liz Ann Sonders discusses the big rally and whether this could be more than an oversold bounce. RockCreek CEO Afseneh Beschloss reveals her best investing opportunities around the globe and the industry she thinks is the “next big thing”. And shares of Biogen and Japanese drugmaker Eisai soaring after positive test results for their experimental Alzheimer’s treatment. Eisai U.S. Chairman & CEO Ivan Cheung on how effective the drug is and when it could win FDA approval. Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com for information about our collection and use of personal data for advertising.

There are no comments yet.

Please log in to write the first comment.